Forma Therapeutics, Inc.
Clinical trials sponsored by Forma Therapeutics, Inc., explained in plain language.
-
Experimental drug aims to free MDS patients from blood transfusions
Disease control TerminatedThis study tested an investigational drug called etavopivat to see if it could safely treat anemia in adults with certain types of myelodysplastic syndromes (MDS), a bone marrow disorder. The main goal was to see if the drug could help patients increase their hemoglobin levels an…
Phase: PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 23:41 UTC
-
Early trial halted for experimental fatty liver drug
Disease control TerminatedThis early-stage study aimed to test the safety and initial effectiveness of an investigational drug called FT-4101 for people with NASH, a serious type of fatty liver disease, who are also overweight or obese. It involved a small group of 14 participants and was designed to see …
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC